A commercial-stage biotechnology company developing tumor-infiltrating lymphocyte (TIL) therapies for cancer, an approach that uses a patient’s own immune cells to target tumors. Iovance Holdings focuses on cell therapies for solid tumors, including lifileucel for advanced melanoma, and is building ...
1 member of Congress has disclosed 5 trades in Iovance Holdings Inc (IOVA), a Healthcare company. The buy/sell breakdown shows 3 purchases versus 2 sales, indicating net buying interest from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2025-04-15 | Rohit Khanna | buy | $1K – $15K |
| 2024-05-28 | Rohit Khanna | sell | $1K – $15K |
| 2024-04-23 | Rohit Khanna | sell | $1K – $15K |
| 2023-12-05 | Rohit Khanna | buy | $1K – $15K |
| 2022-05-26 | Rohit Khanna | buy | $1K – $15K |